Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Bill Ackman Kept Buying Family Dollar Even After the Ira Sohn Conference $FDO

Pershing Square’s Bill Ackman disclosed today that he kept buying Family Dollar (FDO) even after his presentation at the Ira Sohn Conference. Insider Monkey already transcribed that presentation for you, so you can read his reasoning behind this investment. Ackman now owns 10.9 million shares or 8.9% of the company. Two weeks ago Ackman had only 5.8 Million shares. On May 25th, the day Ackman presented his thesis, FDO closed at $54.82. Today the stock jumped more than a dollar after Ackman’s 13G filing. It closed at $52.57.

Bill Ackman PERSHING SQUARE

Here are the list of other hedge fund managers with positions in FDO at the end of first quarter:

1. Nelson Peltz – Trian Partners: $318 Million position

2. Stephen Mandel – Lone Pine Capital: $289 Million position

3. John Paulson – Paulson & Co.: $177 Million

4. James Dinan – York Capital: $101 Million

5. Eric Mindich – Eton Park Capital: $91 Million

6. Jim Simons – Renaissance: $91 Million

7. D.E. Shaw – D.E. Shaw: $76 Million

8. Pavel Begun – 3G Capital: $38 Million

As one can see Bill Ackman is hardly the first investor who is bullish about FDO. Now you can buy this stock at a $2 discount to what was paid by some investors right after Ackman presented.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!